Literature DB >> 18342983

Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship.

Pierre-Jean Wipff1, Boris Hinz.   

Abstract

Integrins are crucial for the ability of cells to sense mechanical perturbations and to transmit intracellular stress to their environment. We here review the more recently discovered role of integrins in activating the pleiotrophic cytokine transforming growth factor beta 1 (TGF-beta1). TGF-beta1 controls tissue homeostasis in embryonic and normal adult tissues and contributes to the development of fibrosis, cancer, autoimmune and vascular diseases when being mis-regulated. In most of these conditions, active TGF-beta1 is generated by dissociation from a large latent protein complex that sequesters latent TGF-beta1 in the extracellular matrix (ECM). Two main models are proposed how integrins contribute to latent TGF-beta1 activation: (1) In a protease-dependent mechanism, integrins alphavbeta8 and alphavbeta3 are suggested to simultaneously bind the latent TGF-beta1 complex and proteinases. This close vicinity at the cell surface improves enzymatic cleavage of the latent complex to release active TGF-beta1. (2) Integrins alphavbeta3, alphavbeta5, alphavbeta6, and alphavbeta8 appear to change the conformation of the latent TGF-beta1 complex by transmitting cell traction forces. This action requires association of the latent complex with a mechanically resistant ECM and is independent from proteolysis. Understanding that different integrins use different mechanisms to activate latent TGF-beta1 opens new possibilities to develop cell-specific therapeutic strategies for TGF-beta1-induced pathologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342983     DOI: 10.1016/j.ejcb.2008.01.012

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  220 in total

1.  Differentiated intestinal epithelial cells express high levels of TGF-β receptors and exhibit increased sensitivity to growth inhibition.

Authors:  Navneeta Rathor; Shelley R Wang; Elizabeth T Chang; Jaladanki N Rao
Journal:  Int J Clin Exp Med       Date:  2011-11-10

Review 2.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

3.  αVβ6 integrin promotes corneal wound healing.

Authors:  José Tomás Blanco-Mezquita; Audrey E K Hutcheon; Mary Ann Stepp; James D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

4.  Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments.

Authors:  Ashley C Brown; Jessica A Rowe; Thomas H Barker
Journal:  Tissue Eng Part A       Date:  2010-12-12       Impact factor: 3.845

5.  Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.

Authors:  Christian Schachtrup; Jae K Ryu; Matthew J Helmrick; Eirini Vagena; Dennis K Galanakis; Jay L Degen; Richard U Margolis; Katerina Akassoglou
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

6.  A molecular classifier for predicting future graft loss in late kidney transplant biopsies.

Authors:  Gunilla Einecke; Jeff Reeve; Banu Sis; Michael Mengel; Luis Hidalgo; Konrad S Famulski; Arthur Matas; Bert Kasiske; Bruce Kaplan; Philip F Halloran
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 7.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

8.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 9.  The myofibroblast, a key cell in normal and pathological tissue repair.

Authors:  Ian A Darby; Noraina Zakuan; Fabrice Billet; Alexis Desmoulière
Journal:  Cell Mol Life Sci       Date:  2015-12-17       Impact factor: 9.261

Review 10.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.